DiscoverNewsRamp Science, Exploration and Discovery PodcastBreaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies
Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

Update: 2024-08-01
Share

Description

Join us as we explore Theriva Biologics' innovative approach to oncolytic virus therapies, aimed at improving survival rates for difficult-to-treat cancers like brain tumors and pancreatic cancers. Learn about their leading candidate, VCN-01, and the promising results seen in clinical trials for various types of cancer. Discover how Theriva is pushing the boundaries with next-generation viruses like VCN-11 with Albumin Shield technology, paving the way for future advancements in cancer treatment.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

NewsRamp